Release date: 2024-07-09 16:45:22 Recommended: 154

Cabometyx tablets are suitable for the treatment of advanced renal cell carcinoma (RCC) patients, and in combination with nivolumab, they are suitable for first-line treatment of advanced RCC patients; Suitable for treating hepatocellular carcinoma (HCC) patients who have previously received sorafenib treatment; Suitable for treating adult and pediatric patients aged 12 and above with locally advanced or metastatic differentiated thyroid cancer (DTC), who have progressed after previous VEGFR targeted therapy and are refractory or unqualified to radioactive iodine.
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of L···【more】
Recommended:400Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appoint···【more】
Recommended:397Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensi···【more】
Recommended:459Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in t···【more】
Recommended:325Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has ···【more】
Recommended:533Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea···【more】
Recommended:325Release date: 2024-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended:507Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended:399Release date: 2024-07-09
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the r···【more】
Recommended:159Release date: 2025-12-17
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved nirap···【more】
Recommended:153Release date: 2025-12-15
The U.S. Food and Drug Administration (FDA) announced today that it has approved···【more】
Recommended:171Release date: 2025-12-10
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisoca···【more】
Recommended:153Release date: 2025-12-08
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full ap···【more】
Recommended:187Release date: 2025-12-04
Primary analysis data from the randomized, double-blind, placebo-controlled phas···【more】
Recommended:167Release date: 2025-12-01